Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Elevated Proangiogenic Markers are Associated with Vascular Complications within Ghanaian Sickle Cell Disease Patients.

Antwi-Boasiako C, Frimpong E, Gyan B, Kyei-Baafour E, Sey F, Dzudzor B, Abdul-Rahman M, Dankwah GB, Otu KH, Ndanu TA, Campbell AD, Ekem I, Donkor ES.

Med Sci (Basel). 2018 Jun 27;6(3). pii: E53. doi: 10.3390/medsci6030053.

2.

CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype.

Candido JB, Morton JP, Bailey P, Campbell AD, Karim SA, Jamieson T, Lapienyte L, Gopinathan A, Clark W, McGhee EJ, Wang J, Escorcio-Correia M, Zollinger R, Roshani R, Drew L, Rishi L, Arkell R, Evans TRJ, Nixon C, Jodrell DI, Wilkinson RW, Biankin AV, Barry ST, Balkwill FR, Sansom OJ.

Cell Rep. 2018 May 1;23(5):1448-1460. doi: 10.1016/j.celrep.2018.03.131.

3.

Wnt ligands influence tumour initiation by controlling the number of intestinal stem cells.

Huels DJ, Bruens L, Hodder MC, Cammareri P, Campbell AD, Ridgway RA, Gay DM, Solar-Abboud M, Faller WJ, Nixon C, Zeiger LB, McLaughlin ME, Morrissey E, Winton DJ, Snippert HJ, van Rheenen J, Sansom OJ.

Nat Commun. 2018 Mar 19;9(1):1132. doi: 10.1038/s41467-018-03426-2.

4.

Disseminated Intravascular Coagulation and Acute Liver Injury from Ethanol Embolization of an Arteriovenous Malformation.

Hage A, Chick JFB, Srinivasa RN, Kuo KW, Kohne JG, Campbell AD, Gemmete JJ.

J Vasc Interv Radiol. 2018 Mar;29(3):437-439. doi: 10.1016/j.jvir.2017.09.021. No abstract available.

PMID:
29455883
5.

Base-Catalyzed Aryl-B(OH)2 Protodeboronation Revisited: From Concerted Proton Transfer to Liberation of a Transient Aryl Anion.

Cox PA, Reid M, Leach AG, Campbell AD, King EJ, Lloyd-Jones GC.

J Am Chem Soc. 2017 Sep 20;139(37):13156-13165. doi: 10.1021/jacs.7b07444. Epub 2017 Sep 11.

PMID:
28823150
6.

An analysis of inpatient pediatric sickle cell disease: Incidence, costs, and outcomes.

Bou-Maroun LM, Meta F, Hanba CJ, Campbell AD, Yanik GA.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26758. Epub 2017 Aug 12.

PMID:
28801954
7.

TGFβ pathway limits dedifferentiation following WNT and MAPK pathway activation to suppress intestinal tumourigenesis.

Cammareri P, Vincent DF, Hodder MC, Ridgway RA, Murgia C, Nobis M, Campbell AD, Varga J, Huels DJ, Subramani C, Prescott KLH, Nixon C, Hedley A, Barry ST, Greten FR, Inman GJ, Sansom OJ.

Cell Death Differ. 2017 Oct;24(10):1681-1693. doi: 10.1038/cdd.2017.92. Epub 2017 Jun 16.

8.

Phosphorylation of Rab-coupling protein by LMTK3 controls Rab14-dependent EphA2 trafficking to promote cell:cell repulsion.

Gundry C, Marco S, Rainero E, Miller B, Dornier E, Mitchell L, Caswell PT, Campbell AD, Hogeweg A, Sansom OJ, Morton JP, Norman JC.

Nat Commun. 2017 Mar 15;8:14646. doi: 10.1038/ncomms14646.

9.

Meals Enhancing Nutrition After Discharge: Findings from a Pilot Randomized Controlled Trial.

Buys DR, Campbell AD, Godfryd A, Flood K, Kitchin E, Kilgore ML, Allocca S, Locher JL.

J Acad Nutr Diet. 2017 Apr;117(4):599-608. doi: 10.1016/j.jand.2016.11.005. Epub 2017 Jan 5.

10.

Genome-wide in vivo screen identifies novel host regulators of metastatic colonization.

van der Weyden L, Arends MJ, Campbell AD, Bald T, Wardle-Jones H, Griggs N, Velasco-Herrera MD, Tüting T, Sansom OJ, Karp NA, Clare S, Gleeson D, Ryder E, Galli A, Tuck E, Cambridge EL, Voet T, Macaulay IC, Wong K; Sanger Mouse Genetics Project, Spiegel S, Speak AO, Adams DJ.

Nature. 2017 Jan 12;541(7636):233-236. doi: 10.1038/nature20792. Epub 2017 Jan 4.

11.

Effect of single agent high-dose methotrexate-related acute kidney injury on length of hospitalization and relative dose intensity in adult patients with central nervous system lymphoma.

Steward JS, Bullard HM, O'Rourke TJ, Campbell AD, Brinker BT, Yost KJ, Vanderwoude AC, Scott WL, Kintzel PE.

J Oncol Pharm Pract. 2017 Oct;23(7):496-501. doi: 10.1177/1078155216665244. Epub 2016 Aug 19.

PMID:
27543094
12.

The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma.

Birch J, Clarke CJ, Campbell AD, Campbell K, Mitchell L, Liko D, Kalna G, Strathdee D, Sansom OJ, Neilson M, Blyth K, Norman JC.

Biol Open. 2016 Oct 15;5(10):1371-1379. doi: 10.1242/bio.019075.

13.

Protodeboronation of Heteroaromatic, Vinyl, and Cyclopropyl Boronic Acids: pH-Rate Profiles, Autocatalysis, and Disproportionation.

Cox PA, Leach AG, Campbell AD, Lloyd-Jones GC.

J Am Chem Soc. 2016 Jul 27;138(29):9145-57. doi: 10.1021/jacs.6b03283. Epub 2016 Jul 15.

PMID:
27355973
14.

mTOR Inhibition improves anaemia and reduces organ damage in a murine model of sickle cell disease.

Wang J, Tran J, Wang H, Guo C, Harro D, Campbell AD, Eitzman DT.

Br J Haematol. 2016 Aug;174(3):461-9. doi: 10.1111/bjh.14057. Epub 2016 Mar 31.

15.

The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β(0) -thalassaemia homozygotes.

Jiang Z, Luo HY, Huang S, Farrell JJ, Davis L, Théberge R, Benson KA, Riolueang S, Viprakasit V, Al-Allawi NA, Ünal S, Gümrük F, Akar N, Başak AN, Osorio L, Badens C, Pissard S, Joly P, Campbell AD, Gallagher PG, Steinberg MH, Forget BG, Chui DH.

Br J Haematol. 2016 Mar;172(6):958-65. doi: 10.1111/bjh.13909. Epub 2016 Jan 13.

16.

Intravital FRAP Imaging using an E-cadherin-GFP Mouse Reveals Disease- and Drug-Dependent Dynamic Regulation of Cell-Cell Junctions in Live Tissue.

Erami Z, Herrmann D, Warren SC, Nobis M, McGhee EJ, Lucas MC, Leung W, Reischmann N, Mrowinska A, Schwarz JP, Kadir S, Conway JRW, Vennin C, Karim SA, Campbell AD, Gallego-Ortega D, Magenau A, Murphy KJ, Ridgway RA, Law AM, Walters SN, Grey ST, Croucher DR, Zhang L, Herzog H, Hardeman EC, Gunning PW, Ormandy CJ, Evans TRJ, Strathdee D, Sansom OJ, Morton JP, Anderson KI, Timpson P.

Cell Rep. 2016 Jan 5;14(1):152-167. doi: 10.1016/j.celrep.2015.12.020. Epub 2015 Dec 24.

17.

Counseling for the Wilderness Athlete and Adventurer During a Preparticipation Evaluation for Preparation, Safety, and Injury Prevention.

Young JM, Campbell AD, Raastad KK.

Wilderness Environ Med. 2015 Dec;26(4 Suppl):S92-7. doi: 10.1016/j.wem.2015.09.015. Review.

PMID:
26617383
18.

Preparticipation Evaluation for Climbing Sports.

Campbell AD, Davis C, Paterson R, Cushing TA, Ng P, Peterson CS, Sedgwick PE, McIntosh SE.

Wilderness Environ Med. 2015 Dec;26(4 Suppl):S40-6. doi: 10.1016/j.wem.2015.09.014. Review.

PMID:
26617377
19.

Risk Stratification for Athletes and Adventurers in High-Altitude Environments: Recommendations for Preparticipation Evaluation.

Campbell AD, McIntosh SE, Nyberg A, Powell AP, Schoene RB, Hackett P.

Wilderness Environ Med. 2015 Dec;26(4 Suppl):S30-9. doi: 10.1016/j.wem.2015.09.016. Review.

PMID:
26617376
20.

Ethical, Legal, and Administrative Considerations for Preparticipation Evaluation for Wilderness Sports and Adventures.

Young CC, Campbell AD, Lemery J, Young DS.

Wilderness Environ Med. 2015 Dec;26(4 Suppl):S10-4. doi: 10.1016/j.wem.2015.09.013. Review.

PMID:
26617373
21.

Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.

Tatari-Calderone Z, Gordish-Dressman H, Fasano R, Riggs M, Fortier C, Campbell AD, Charron D, Gordeuk VR, Luban NL, Vukmanovic S, Tamouza R.

Hum Immunol. 2016 Jan;77(1):35-40. doi: 10.1016/j.humimm.2015.10.010. Epub 2015 Oct 22.

22.

TR2/TR4 overexpression in a humanized sickle cell disease mouse model decreases RBC adhesion to VCAM-1.

White JC, Pawar A, Fu G, Cui S, Tavernier F, Hamid M, Harro D, Giacherio D, Campbell AD, Hines PC.

Blood Cells Mol Dis. 2015 Dec;55(4):316-7. doi: 10.1016/j.bcmd.2015.07.003. Epub 2015 Jul 6. No abstract available.

PMID:
26460253
23.

Hereditary Persistence of Fetal Hemoglobin Caused by Single Nucleotide Promoter Mutations in Sickle Cell Trait and Hb SC Disease.

Akinbami AO, Campbell AD, Han ZJ, Luo HY, Chui DH, Steinberg MH.

Hemoglobin. 2016;40(1):64-5. doi: 10.3109/03630269.2015.1080725. Epub 2015 Sep 15.

PMID:
26372199
24.

Counseling for the Wilderness Athlete and Adventurer During a Preparticipation Evaluation for Preparation, Safety, and Injury Prevention.

Young JM, Campbell AD, Raastad KK.

Clin J Sport Med. 2015 Sep;25(5):456-60. doi: 10.1097/JSM.0000000000000250. Review.

PMID:
26340739
25.

Preparticipation Evaluation for Climbing Sports.

Campbell AD, Davis C, Paterson R, Cushing TA, Ng P, Peterson CS, Sedgwick PE, McIntosh SE.

Clin J Sport Med. 2015 Sep;25(5):412-7. doi: 10.1097/JSM.0000000000000247. Review.

PMID:
26340733
26.

Risk Stratification for Athletes and Adventurers in High-Altitude Environments: Recommendations for Preparticipation Evaluation.

Campbell AD, McIntosh SE, Nyberg A, Powell AP, Schoene RB, Hackett P.

Clin J Sport Med. 2015 Sep;25(5):404-11. doi: 10.1097/JSM.0000000000000231. Review. Erratum in: Clin J Sport Med. 2015 Nov;25(6):553.

PMID:
26340732
27.

Ethical, Legal, and Administrative Considerations for Preparticipation Evaluation for Wilderness Sports and Adventures.

Young CC, Campbell AD, Lemery J, Young DS.

Clin J Sport Med. 2015 Sep;25(5):388-91. doi: 10.1097/JSM.0000000000000246. Review.

PMID:
26340729
28.

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.

Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L.

Nat Commun. 2015 Aug 26;6:8093. doi: 10.1038/ncomms9093.

29.

E-cadherin can limit the transforming properties of activating β-catenin mutations.

Huels DJ, Ridgway RA, Radulescu S, Leushacke M, Campbell AD, Biswas S, Leedham S, Serra S, Chetty R, Moreaux G, Parry L, Matthews J, Song F, Hedley A, Kalna G, Ceteci F, Reed KR, Meniel VS, Maguire A, Doyle B, Söderberg O, Barker N, Watson A, Larue L, Clarke AR, Sansom OJ.

EMBO J. 2015 Sep 14;34(18):2321-33. doi: 10.15252/embj.201591739. Epub 2015 Aug 3.

30.

Melanoma tumor growth is accelerated in a mouse model of sickle cell disease.

Wang J, Tran J, Wang H, Luo W, Guo C, Harro D, Campbell AD, Eitzman DT.

Exp Hematol Oncol. 2015 Jul 7;4:19. doi: 10.1186/s40164-015-0014-1. eCollection 2015.

31.

Does Participation in Home-Delivered Meals Programs Improve Outcomes for Older Adults? Results of a Systematic Review.

Campbell AD, Godfryd A, Buys DR, Locher JL.

J Nutr Gerontol Geriatr. 2015;34(2):124-67. doi: 10.1080/21551197.2015.1038463. Review.

32.

A pilot study to promote walking among obese and overweight individuals: walking buses for adults.

Baker EH, Milner AN, Campbell AD.

Public Health. 2015 Jun;129(6):822-4. doi: 10.1016/j.puhe.2015.03.021. Epub 2015 May 1. No abstract available.

33.

Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis.

von Karstedt S, Conti A, Nobis M, Montinaro A, Hartwig T, Lemke J, Legler K, Annewanter F, Campbell AD, Taraborrelli L, Grosse-Wilde A, Coy JF, El-Bahrawy MA, Bergmann F, Koschny R, Werner J, Ganten TM, Schweiger T, Hoetzenecker K, Kenessey I, Hegedüs B, Bergmann M, Hauser C, Egberts JH, Becker T, Röcken C, Kalthoff H, Trauzold A, Anderson KI, Sansom OJ, Walczak H.

Cancer Cell. 2015 Apr 13;27(4):561-73. doi: 10.1016/j.ccell.2015.02.014. Epub 2015 Apr 2.

34.

A patient's request for steroids to enhance participation in wilderness sport and adventure.

Madden C, Campbell AD, Pierce J.

Virtual Mentor. 2014 Jul 1;16(7):534-8. doi: 10.1001/virtualmentor.2014.16.07.ecas2-1407. No abstract available.

PMID:
25013918
35.

Black megachurch websites: an assessment of health content for congregations and communities.

Campbell AD, Wallace G.

Health Commun. 2015;30(6):557-65. doi: 10.1080/10410236.2013.872964. Epub 2014 Jul 3.

PMID:
24992003
36.

Increased stroke size following MCA occlusion in a mouse model of sickle cell disease.

Luo W, Su EJ, Wang J, Wang H, Guo C, Pawar A, Campbell AD, Lawrence DA, Eitzman DT.

Blood. 2014 Mar 20;123(12):1965-7. doi: 10.1182/blood-2014-01-549717. No abstract available.

37.

Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ, Campbell AD, Rana SR, Niu XM, Machado RF, Gladwin MT, Gordeuk VR.

Paediatr Respir Rev. 2014 Mar;15(1):4-12. doi: 10.1016/j.prrv.2013.11.003. Epub 2013 Nov 15. Review.

38.

First trial and StartReact effects induced by balance perturbations to upright stance.

Campbell AD, Squair JW, Chua R, Inglis JT, Carpenter MG.

J Neurophysiol. 2013 Nov;110(9):2236-45. doi: 10.1152/jn.00766.2012. Epub 2013 Aug 14.

39.

Intravital FLIM-FRET imaging reveals dasatinib-induced spatial control of src in pancreatic cancer.

Nobis M, McGhee EJ, Morton JP, Schwarz JP, Karim SA, Quinn J, Edward M, Campbell AD, McGarry LC, Evans TR, Brunton VG, Frame MC, Carragher NO, Wang Y, Sansom OJ, Timpson P, Anderson KI.

Cancer Res. 2013 Aug 1;73(15):4674-86. doi: 10.1158/0008-5472.CAN-12-4545. Epub 2013 Jun 7.

40.

Paradoxical protection from atherosclerosis and thrombosis in a mouse model of sickle cell disease.

Wang H, Luo W, Wang J, Guo C, Wolffe SL, Wang J, Sun EB, Bradley KN, Campbell AD, Eitzman DT.

Br J Haematol. 2013 Jul;162(1):120-9. doi: 10.1111/bjh.12342. Epub 2013 Apr 17.

41.

P-Rex1 cooperates with PDGFRβ to drive cellular migration in 3D microenvironments.

Campbell AD, Lawn S, McGarry LC, Welch HC, Ozanne BW, Norman JC.

PLoS One. 2013;8(1):e53982. doi: 10.1371/journal.pone.0053982. Epub 2013 Jan 30.

42.

Startle induces early initiation of classically conditioned postural responses.

Campbell AD, Chua R, Inglis JT, Carpenter MG.

J Neurophysiol. 2012 Dec;108(11):2946-56. doi: 10.1152/jn.01157.2011. Epub 2012 Sep 12.

43.

Who counsels parents of newborns who are carriers of sickle cell anemia or cystic fibrosis?

Moseley KL, Nasr SZ, Schuette JL, Campbell AD.

J Genet Couns. 2013 Apr;22(2):218-25. doi: 10.1007/s10897-012-9537-3. Epub 2012 Aug 18.

PMID:
22903793
44.

The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity.

Cumming JG, Bower JF, Waterson D, Faull A, Poyser PJ, Turner P, McDermott B, Campbell AD, Hudson J, James M, Winter J, Wood C.

Bioorg Med Chem Lett. 2012 Jun 15;22(12):3895-9. doi: 10.1016/j.bmcl.2012.04.118. Epub 2012 May 2.

PMID:
22608963
45.

Single-session biofeedback-assisted relaxation training in children with sickle cell disease.

Myrvik MP, Campbell AD, Butcher JL.

J Pediatr Hematol Oncol. 2012 Jul;34(5):340-3. doi: 10.1097/MPH.0b013e318253f0ba.

PMID:
22584783
46.

P-Rex1 is required for efficient melanoblast migration and melanoma metastasis.

Lindsay CR, Lawn S, Campbell AD, Faller WJ, Rambow F, Mort RL, Timpson P, Li A, Cammareri P, Ridgway RA, Morton JP, Doyle B, Hegarty S, Rafferty M, Murphy IG, McDermott EW, Sheahan K, Pedone K, Finn AJ, Groben PA, Thomas NE, Hao H, Carson C, Norman JC, Machesky LM, Gallagher WM, Jackson IJ, Van Kempen L, Beermann F, Der C, Larue L, Welch HC, Ozanne BW, Sansom OJ.

Nat Commun. 2011 Nov 22;2:555. doi: 10.1038/ncomms1560.

47.

Reduced time for urinary alkalinization before high-dose methotrexate with preadmission oral bicarbonate.

Kintzel PE, Campbell AD, Yost KJ, Brinker BT, Arradaza NV, Frobish D, Wehr AM, O'Rourke TJ.

J Oncol Pharm Pract. 2012 Jun;18(2):239-44. doi: 10.1177/1078155211426913. Epub 2011 Nov 10.

PMID:
22075004
48.

Forced TR2/TR4 expression in sickle cell disease mice confers enhanced fetal hemoglobin synthesis and alleviated disease phenotypes.

Campbell AD, Cui S, Shi L, Urbonya R, Mathias A, Bradley K, Bonsu KO, Douglas RR, Halford B, Schmidt L, Harro D, Giacherio D, Tanimoto K, Tanabe O, Engel JD.

Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18808-13. doi: 10.1073/pnas.1104964108. Epub 2011 Oct 31.

49.

Attitudes of Ghanaian women toward genetic testing for sickle cell trait.

Ross PT, Lypson ML, Ursu DC, Everett LA, Rodrigues O, Campbell AD.

Int J Gynaecol Obstet. 2011 Dec;115(3):264-8. doi: 10.1016/j.ijgo.2011.08.004. Epub 2011 Oct 8.

50.

Clofarabine-associated acute kidney injury and proteinuria.

Kintzel PE, Visser JA, Campbell AD.

Pharmacotherapy. 2011 Sep;31(9):923. doi: 10.1592/phco.31.9.923.

PMID:
21923594

Supplemental Content

Loading ...
Support Center